Revenue, 2023 (US$M)
$198.6
Forecast, 2030 (US$M)
$346.5
CAGR, 2024 - 2030
8.3%
Report Coverage
Middle East & Africa

MEA ruminant vaccines market highlights

  • The MEA ruminant vaccines market generated a revenue of USD 198.6 million in 2023.
  • The market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
  • In terms of segment, modified/ attenuated live was the largest revenue generating vaccine type in 2023.
  • Other Vaccines is the most lucrative vaccine type segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.

MEA data book summary

Market revenue in 2023USD 198.6 million
Market revenue in 2030USD 346.5 million
Growth rate8.3% (CAGR from 2023 to 2030)
Largest segmentModified/ attenuated live
Fastest growing segmentOther Vaccines
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationModified/ Attenuated Live, Inactivated (Killed), Other Vaccines
Key market players worldwideBoehringer Ingelheim, Zoetis, Merck & Co Inc, Indian Immunologicals, Elanco Animal Health Inc, Virbac SA, Ceva Santé Animale

Other key industry trends

  • In terms of revenue, MEA region accounted for 5.8% of the global ruminant vaccines market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 831.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Ruminant Vaccines Market Scope

Ruminant vaccines market segmentation & scope

Ruminant Vaccines Market Companies

Name Profile # Employees HQ Website

Middle East & Africa ruminant vaccines market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ruminant vaccines market will help companies and investors design strategic landscapes.


Modified/ attenuated live was the largest segment with a revenue share of 51.61% in 2023. Horizon Databook has segmented the Middle East & Africa ruminant vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines covering the revenue growth of each sub-segment from 2018 to 2030.


  • Middle East & Africa Ruminant Vaccines Vaccine Type Outlook (Revenue, USD Million, 2018-2030)
    • Modified/ Attenuated Live
    • Inactivated (Killed)
    • Other Vaccines
    • Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids)
  • Middle East & Africa Ruminant Vaccines Route of Administration Outlook (Revenue, USD Million, 2018-2030)
    • Injectable
    • Others (e.g. Intranasal)
    • Others (e.g. Oral, Intranasal)
    • Others (e.g. Oral, Oculo-nasal etc.)
    • Others (e.g. Immersion & Spray, Oral)

Reasons to subscribe to Middle East & Africa ruminant vaccines market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa ruminant vaccines market databook

  • Our clientele includes a mix of ruminant vaccines market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa ruminant vaccines market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa ruminant vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA ruminant vaccines market size, by country, 2018-2030 (US$M)

Middle East & Africa Ruminant Vaccines Market Outlook Share, 2023 & 2030 (US$M)

MEA ruminant vaccines market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more